Access earnings results, analyst expectations, report, slides, earnings call, and transcript.
The earnings call highlights significant challenges: decreased revenue in key segments, margin pressures, and a net loss despite some growth in specific areas like grains and Crop Care. The Q&A reveals uncertainties in future revenue and no expectation of further pricing cuts, which could stabilize margins. However, the overall sentiment remains negative due to ongoing financial pressures, adverse market conditions, and a weak adjusted EBITDA. Without a market cap, the stock's reaction is uncertain, but the negative financial trends suggest a likely decline in stock price.
Consolidated Revenue $514.2 million, up 6% year-over-year; driven by robust volume growth from recent M&A and currency tailwinds, offset by deflationary headwinds from input price declines.
Inputs Revenue Decreased by 1% year-over-year; impacted by input price deflation and adverse effects of drought, despite significant volume increases.
Grain Revenue Increased by 61% to $87.5 million; driven by greater desire for barter transactions among farmer clients.
Brazil Ag Retail Revenue Increased by 5% to $450 million; reflecting higher grains revenue and contributions from recent acquisitions.
Inputs Revenue (Brazil Ag Retail) Decreased by 3% to $363.2 million; impacted by input price deflation and drought conditions.
Latin Ag Retail Revenue Increased by 5% to $50.5 million; growth led by currency tailwinds and robust fertilizer sales volume.
Crop Care Revenue Grew 30% to $22.1 million; led by biologicals and contributions from recent acquisitions.
Consolidated Gross Profit Decreased by 16% to $60.2 million; gross margin contracted by 310 basis points due to increased grains revenue mix and inflationary pressures.
Brazil Ag Retail Gross Margin Contracted by 240 basis points to 9.7%; impacted by input price declines.
Latam Ag Retail Segment Profit $7.3 million, a decrease of 4% year-over-year; gross margins declined due to pricing deflation.
Crop Care Segment Gross Profit Grew 14% to $9.1 million; gross margin decreased by 550 basis points due to tactical price reductions and negative product mix.
Net Loss $64.8 million, improved from a net loss of $74.3 million year-over-year; improvement due to absence of one-time expenses, offset by decreased gross profits and increased SG&A.
Adjusted EBITDA $3.7 million, down from $24.8 million year-over-year; adjusted EBITDA margin contracted by 440 basis points due to gross margin pressure and increased SG&A.
Adjusted Net Loss $62.7 million, compared to $7.9 million in the prior year; driven by lower non-recurring expenses.
Crop Care Revenue Growth: Crop Care segment revenue grew 30% to $22.1 million for Q3 2024, led by biologicals, which grew 53% year-over-year.
Agrobiologica Revenue Growth: Agrobiologica, the biological business, saw revenue increase by 57%, driven by strong demand for bioinsecticide products.
Market Share Gains: Lavoro continues to outperform the Brazil retail inputs market with robust double-digit volume growth and market share gains.
Retail Ag Inputs Market Performance: The Brazilian retail inputs market shrank by over 25%, while Lavoro's inputs revenue decreased by only 7% year-over-year.
Recruitment of Agronomists: Proactive recruitment of seasoned agronomists resulted in an additional $35 million in future net sales potential from new hires.
Credit Policy Impact: Stringent credit standards shielded Lavoro from significant surprises, but payment delays were observed, impacting fourth quarter results.
Guidance Revision: Fiscal year 2024 revenue is projected to range between $1.8 billion and $1.95 billion, with adjusted EBITDA between $46 million and $55 million.
Future Market Outlook: For crop year '24-'25, Lavoro expects to continue outpacing the market driven by market share gains and improved gross margins.
Market Conditions: The Brazilian agricultural market is facing severe challenges due to extreme weather events, particularly drought caused by El Nino, which has negatively impacted farmer profitability and purchasing behavior.
Farmer Behavior: Farmers are exhibiting risk-averse behavior, postponing purchasing decisions, which has led to a significant decrease in retail market bookings for the upcoming crop year.
Credit Risks: Delays in farmer repayments to retailers are widespread, exacerbated by lower grain commodity prices and El Nino's impact on profitability. This has led to an increase in expected credit losses.
Supplier Agreements: The company is negatively impacted by bonuses related to supplier agreements that did not materialize as expected, with some shifting to the next fiscal year.
Economic Factors: The overall economic environment is challenging, with input price deflation and inflationary pressures affecting gross margins and profitability.
Guidance Revision: The company has revised its fiscal year 2024 projections downward due to adverse impacts from the aforementioned factors, including expected revenue and adjusted EBITDA declines.
Market Share Growth: Lavoro continues to outperform the Brazil retail inputs market with robust double-digit volume growth and market share gains.
Crop Care Segment Performance: Crop Care segment revenue grew 30% and gross profit increased by 14%, with Agrobiologica revenue rising by 57%.
Recruitment of Agronomists: Proactive recruitment of seasoned agronomists is expected to generate an additional $35 million in future net sales potential.
Fiscal Year 2024 Revenue Guidance: Projected revenue range is $1.8 billion to $1.95 billion.
Input Revenues Guidance: Input revenues are expected to range between $1.6 billion and $1.75 billion.
Adjusted EBITDA Guidance: Adjusted EBITDA is projected to range between $46 million and $55 million.
Fiscal Year 2025 Outlook: Expect to continue outpacing the market driven by market share gains and improved gross margins.
Share Buyback Program: None
The earnings call reveals several negative aspects: increased net loss, credit access challenges, and reduced gross margins. Although revenue increased, significant margin compression and higher finance costs overshadow these gains. The Q&A section indicates concerns about credit lines and unclear management responses, adding to the negative sentiment. With no share repurchase plan and a focus on operational efficiency due to market challenges, the outlook remains bleak. Consequently, the stock price is likely to experience a negative reaction in the coming weeks.
The earnings call highlights significant challenges: decreased revenue in key segments, margin pressures, and a net loss despite some growth in specific areas like grains and Crop Care. The Q&A reveals uncertainties in future revenue and no expectation of further pricing cuts, which could stabilize margins. However, the overall sentiment remains negative due to ongoing financial pressures, adverse market conditions, and a weak adjusted EBITDA. Without a market cap, the stock's reaction is uncertain, but the negative financial trends suggest a likely decline in stock price.
The earnings call reveals mixed signals: while Crop Care revenue and gross profit grew significantly, overall consolidated gross profit and adjusted EBITDA decreased due to input price deflation. The Q&A section highlights uncertainties, such as the impact of safrinha corn sales and farmer bankruptcies. Despite some positive outlooks, like Crop Care's growth and sales staff expansion, the lack of clear guidance and declining financial metrics suggest a neutral sentiment. Without market cap data, the stock reaction is uncertain, but the mixed results and cautious outlook likely lead to a neutral price movement.
The company reported strong financial performance with significant revenue and EBITDA growth, particularly in the Crop Care segment. Despite challenges like postponed acquisitions and regulatory hurdles, the company projects continued revenue growth and has strategies to mitigate pricing headwinds. Positive factors such as increased gross profit and margin expansion, alongside optimistic guidance for FY 2024, outweigh the risks. The earnings call Q&A also highlights robust demand and growth potential, suggesting a positive stock price movement.
All transcripts are sourced directly from the official live webcast or the company’s official investor relations website. We use the exact words spoken during the call with no paraphrasing of the core discussion.
Full verbatim transcripts are typically published within 4–12 hours after the call ends. Same-day availability is guaranteed for all S&P 500 and most mid-cap companies.
No material content is ever changed or summarized in the “Full Transcript” section. We only correct obvious spoken typos (e.g., “um”, “ah”, repeated 10 times”, or clear misspoken ticker symbols) and add speaker names/titles for readability. Every substantive sentence remains 100% as spoken.
When audio quality is poor or multiple speakers talk over each other, we mark the section instead of guessing. This ensures complete accuracy rather than introducing potential errors.
They are generated by a specialized financial-language model trained exclusively on 15+ years of earnings transcripts. The model extracts financial figures, guidance, and tone with 97%+ accuracy and is regularly validated against human analysts. The full raw transcript always remains available for verification.